Abubaker and his colleagues demonstrated that ANGPTL4 and 8 levels were increased in subjects with OSA, suggesting that the upregulation of these lipid metabolism regulators might play a role in the lipid dysregulation observed in patients with OSA [54]. Here, ANGPTL4 is linked to obstructive sleep apnea syndrome.